TEL AVIV (VINnews) — In a potential game-changer for one of medicine’s most devastating diseases, researchers at Tel Aviv University have pioneered an RNA-based gene therapy that halts and even reverses nerve degeneration in models of amyotrophic lateral sclerosis, or ALS, offering fresh hope to millions worldwide battling the incurable neurodegenerative condition. The findings, published | Read More in Virtual Jerusalem